PROSOM TAB 1MG DIN 02016060
Health Canada record
| Active ingredient(s) | ESTAZOLAM 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05CD04 ESTAZOLAM |
| Original market date | 31-Dec-1993 |
| Current status date | 18-Aug-1997 |
| Source | Health Canada DPD |
Establishment licence of the holder
Abbott Laboratories Co. — licence 3-002635, currently licensed, last inspection rating C (2024-09-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ESTAZOLAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02015102 | PROSOM TAB 2MG | ABBOTT LABORATORIES, LIMITED | Tablet | ESTAZOLAM 2 MG | Cancelled Post Market |
International API supply for ESTAZOLAM
3 active FDA Drug Master Files.
Request a quote for PROSOM TAB 1MG